摘要

<正>1文献来源Kudo M,Ueshima K,Ikeda M,et al. Randomised,multicentre prospective trial of transarterial-chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma:TACTICS trial[J]. Gut,2020,69(8):1492-1501.